These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12867703)

  • 1. Brain natriuretic peptide in diagnosis and treatment of heart failure.
    Bhatia V; Nayyar P; Dhindsa S
    J Postgrad Med; 2003; 49(2):182-5. PubMed ID: 12867703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Brain natriuretic Peptide. Diagnostic and prognostic value in chronic heart failure].
    Krüger S; Hoffmann R; Graf J; Janssens U; Hanrath P
    Med Klin (Munich); 2003 Oct; 98(10):562-7. PubMed ID: 14586510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of B-type natriuretic peptide to diagnose congestive heart failure.
    Gray JR
    Clin Lab Sci; 2006; 19(4):214-7. PubMed ID: 17181125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brain natriuretic peptide].
    Tsutamoto T; Horie M
    Rinsho Byori; 2004 Aug; 52(8):655-68. PubMed ID: 15478621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical applications of brain natriuretic peptide testing].
    Scardovi AB; ; ; ; ;
    Ital Heart J Suppl; 2004 May; 5(5):343-56. PubMed ID: 15182061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical value of rapid assay for plasma B-type natriuretic peptide in differentiating congestive heart failure from pulmonary causes of dyspnoea.
    Zhao SQ; Hu YM; Li Q; Liu XR; Wang M; Zhang WY; Wu T; Nie XL; Zhao N; Wang LR
    Int J Clin Pract; 2008 Feb; 62(2):214-20. PubMed ID: 18081799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases.
    Zakynthinos E; Kiropoulos T; Gourgoulianis K; Filippatos G
    Heart Lung; 2008; 37(4):275-85. PubMed ID: 18620103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of brain natriuretic peptide in the management of acute and chronic heart failure in outpatients.
    Safley DM; McCullough PA
    Heart Fail Monit; 2003; 4(1):13-20. PubMed ID: 12808480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of B-type natriuretic peptide in the diagnosis of acute dyspnoea.
    Mueller C; Laule-Kilian K; Christ A; Staub D
    Clin Lab; 2005; 51(1-2):5-9. PubMed ID: 15719699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood volume and brain natriuretic peptide in congestive heart failure: a pilot study.
    James KB; Troughton RW; Feldschuh J; Soltis D; Thomas D; Fouad-Tarazi F
    Am Heart J; 2005 Nov; 150(5):984. PubMed ID: 16290978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monitoring heart failure with brain natriuretic peptide].
    Sela B
    Harefuah; 2003 Jan; 142(1):25-31, 78. PubMed ID: 12647486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure.
    Maisel A
    J Card Fail; 2001 Jun; 7(2):183-93. PubMed ID: 11420771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic peptide measurements in diagnosing congestive heart failure in the dyspneic emergency department patient.
    Maisel A
    Rev Cardiovasc Med; 2002; 3 Suppl 4():S10-7. PubMed ID: 12439426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
    Omland T
    Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide: a diagnostic, prognostic, and therapeutic tool in heart failure.
    Prahash A; Lynch T
    Am J Crit Care; 2004 Jan; 13(1):46-53; quiz 54-5. PubMed ID: 14735647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [B-type natriuretic peptide--current use in the diagnosis and management of heart failure].
    Müller C; Kuster G; Büttner HJ; Buser P
    Herz; 2003 Aug; 28(5):374-9. PubMed ID: 12928736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.